Dissolution Rate and Bioavailability of Spironolactone Tablets: Effect of Various Technological Factors
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 13 (12) , 2301-2314
- https://doi.org/10.3109/03639048709020588
Abstract
The effects of the magnesium stearate, talc and gelatin contents of spironolactone tablets on dissolution rate and bioavailability of the drug have been evaluated. The dissolution test results for eight formulations corresponding to a 2×2×2 factorial design showed dissolution rates to be chiefly dependent on gelatin content. Testing the bioavailability of the eight formulations using a balanced incomplete block design revealed no evidence of bioinequivalence, but in view of the possibility that the absence of significant differences had been due to the large number of formulations (and consequent lack of sensitivity on the part of experimental design) three representative formulations were re-tested using a 3×3 Latin square design. The results confirmed those of the balanced incomplete block study. Use of the balanced incomplete block design is advocated for bioavailability studies in which a large number of formulations are to be compared.This publication has 8 references indexed in Scilit:
- Enhancement of oral bioavailability of spironolactone by .BETA.- and .GAMMA.-cyclodextrin complexations.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- MANOVA of statistical moments in biopharmaceutical studies: A numerical example with three equally spaced doses of amoxicillinJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Statistical moments in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- In Vitro and in vivo Availability of Spironolactone from Various Oral PreparationsDrug Development and Industrial Pharmacy, 1978
- Factors Influencing Comparative Bioavailability of Spironolactone TabletsJournal of Pharmaceutical Sciences, 1977
- A Comparison of the Dissolution and Bioavailability Characteristics of Three Spironolactone Tablet Formulations, Including Preliminary Data on Two Spironolactone MetabolitesJournal of International Medical Research, 1976
- Spironolactone. II. BioavailabilityClinical Pharmacology & Therapeutics, 1976
- EFFECT OF A DETERGENT ON GASTROINTESTINAL ABSORPTION OF A STEROIDThe Lancet, 1961